Last edition
News about "NMPA"
Glenmark Secures Exclusive Multi-Region Rights to Aumolertinib from Hansoh Pharma
Glenmark has entered into an exclusive licensing agreement with Hansoh Pharma to commercialise aumolertinib, a third-generation EGFR-TKI approved by the MHRA and China’s NMPA, across multiple international markets, reinforcing the company’s oncology portfolio and expansion strategy in high-growth regions.
NMPA | 17/12/2025 | By News Bureau
Ronovo Surgical Closes Series D Financing
Ronovo Surgical secures USD 67 million in Series D funding led by JJDC, raising over USD 100 million in 2025 to advance minimally invasive surgery.
NMPA | 06/09/2025 | By Dineshwori | 142
Innovent's DOVBLERON Secures Second NMPA Approval for ROS1-Positive NSCLC
China's National Medical Products Administration (NMPA) has approved the second New Drug Application (NDA) of DOVBLERON®, a next-generation ROS1 tyrosine kinase inhibitor (TKI).
NMPA | 03/01/2025 | By Abha | 241
Gufic receives approval from NMPA, China for Prilocaine API
Gufic receives approval from NMPA, China for Prilocaine API
NMPA | 19/06/2023 | By Sudeep Soparkar | 569
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy